These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 9568638
1. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. Ree AH, Bjørnland K, Brünner N, Johansen HT, Pedersen KB, Aasen AO, Fodstad O. Clin Exp Metastasis; 1998 Apr; 16(3):205-15. PubMed ID: 9568638 [Abstract] [Full Text] [Related]
2. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R. Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654 [Abstract] [Full Text] [Related]
3. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Johnson MD, Torri JA, Lippman ME, Dickson RB. Exp Cell Res; 1999 Feb 25; 247(1):105-13. PubMed ID: 10047452 [Abstract] [Full Text] [Related]
4. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Castelló R, Estellés A, Vázquez C, Falcó C, España F, Almenar SM, Fuster C, Aznar J. Clin Chem; 2002 Aug 25; 48(8):1288-95. PubMed ID: 12142386 [Abstract] [Full Text] [Related]
7. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A, Mackay AR. Int J Cancer; 1998 Mar 02; 75(5):721-30. PubMed ID: 9495240 [Abstract] [Full Text] [Related]
8. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Brünner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R. Cancer Res; 1993 Jan 15; 53(2):283-90. PubMed ID: 8380254 [Abstract] [Full Text] [Related]
9. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. Ellerbroek SM, Hudson LG, Stack MS. Int J Cancer; 1998 Oct 29; 78(3):331-7. PubMed ID: 9766568 [Abstract] [Full Text] [Related]
10. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Invasion Metastasis; 1992 Oct 29; 12(3-4):168-84. PubMed ID: 1284126 [Abstract] [Full Text] [Related]
11. Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression. Ree AH, Maelandsmo GM, Fodstad O. Clin Exp Metastasis; 1996 Sep 29; 14(4):381-8. PubMed ID: 8878412 [Abstract] [Full Text] [Related]
13. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V. Int J Mol Med; 2008 Feb 29; 21(2):251-9. PubMed ID: 18204793 [Abstract] [Full Text] [Related]
14. Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells. Bjørnland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH. Oncol Res; 1998 Feb 29; 10(5):255-62. PubMed ID: 9802060 [Abstract] [Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R, Schaaf A. Int J Oncol; 2009 Jan 29; 34(1):15-23. PubMed ID: 19082473 [Abstract] [Full Text] [Related]
18. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. Chao CY, Lii CK, Hsu YT, Lu CY, Liu KL, Li CC, Chen HW. Carcinogenesis; 2013 Aug 29; 34(8):1843-51. PubMed ID: 23615401 [Abstract] [Full Text] [Related]
19. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum. Kliem H, Welter H, Kraetzl WD, Steffl M, Meyer HH, Schams D, Berisha B. Reproduction; 2007 Sep 29; 134(3):535-47. PubMed ID: 17709571 [Abstract] [Full Text] [Related]
20. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells. Denkert C, Siegert A, Leclere A, Turzynski A, Hauptmann S. Clin Exp Metastasis; 2002 Sep 29; 19(1):79-85. PubMed ID: 11918086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]